The Premier Science Magazine in Sri Lanka
Latest from Sri Lankan Medical Research
In a recent research carried out by group of researchers from University of Colombo and Robert Koch Institute in Germany it was revealed that two cave-dwelling Sri Lankan bat species …
Alpha and Beta Corona-virus Subgroups(NOT Covid Virus Variants) found in another two bat species in Sri Lanka Read More
With some hiccups here and there the COVID vaccination in Sri Lanka is slowly getting in to a well organized program even with the limited stocks of vaccines the country is receiving from different sources and manufactures. Recently Sri Lankan health authorities published a priority list categorizing different groups of the society in to an order to receive the vaccine. According to this list Healthcare workers, Elderly citizens who are over 60 yrs old, and pregnant women get the priority in vaccination programs.
No COVID Vaccines for Children Yet, but WHY? WHO Expert Explains Read More
Researchers running the University of Oxford-led Com-COV study – launched earlier this year to investigate alternating doses of the Oxford-AstraZeneca and the Pfizer vaccine – have last week reported preliminary data revealing more frequent mild to moderate reactions in mixed schedules compared to standard schedules.
Mixing and Matching Vaccines May Cause Troubles: Oxford Research Read More
In the recent times it has been observed that there is an increase of contamination incidences among the COVID testing laboratories in the country. Because of these incidents an alarming delay in COVID 19 testing has been reported in these laboratories. So decontamination of these laboratories is an important factor in keeping these laboratories running in these tough conditions.
The importance of regular decontamination in COVID testing laboratories Read More
Yesterday, 6th April 2021, the Russian Ministry of Health, the Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announced that Sputnik Light, a single dose COVID-19 vaccine, has received authorization for use in Russia.
Sputnik Light, the Single Dose Version of Sputnik V Authorized in Russia Read More
Sputnik V vaccine, a product of Russian Research facility, Gamaleya Research Institute of Epidemiology and Microbiology is one of the main vaccination candidate Sri Lanka is looking forward to acquire in mass scale. The first consignment of Sputnik V Vaccine with 15000 doses arrived in Sri Lanka yesterday, 4th May 2021. According to state officials Sri Lanka is to receive 13 million doses of this Sputnik V vaccine in near future.
Sputnik V; the Russian Weapon Against the COVID 19 Pandemic Read More
In a special press release today, 1st of May 2021 the Sri Lanka Institute of Nanotechnology (SLINTEC) announced obtaining the GMP license from NMRA for manufacturing their COVID 19 Rapid Test Kit RT-LAMP.
SLINTEC Obtains NMRA GMP License for Their COVID Test Kit, Commercial Manufacturing to Commence Soon Read More
In a special announcement today the scientists at Sri Jayewardenepura University revealed the COVID 19 virus strain behind the recent increase of the cases to be the variant B.1.1.7 which was first identified in United Kingdom during the month September 2020. According to the observations in UK this variant was found to be associated with increased admissibility and higher virulance.
COVID Variant B.1.1.7: Some Key Facts You Should Know Read More
In a special event held today a group of scientists from the University of Peradeniya introduced a new face mask with a 99% efficiency in removing and repelling harmful organisms …
Sri Lankan Scientists Introduce a Face Mask Made from Materials Improved with Nanotechnology Read More
With the entire world is looking forward to a successful vaccine against the deadly COVID 19 Pandemic two countries who are well ahead in the vaccine production race will begin …
Russia to Begin Mass Scale Vaccination Against COVID 19 While UK Authorize The Pfizer/Biontech COVID 19 Vaccine for General Use Read More